Edap Tms (NASDAQ:EDAP) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Edap Tms (NASDAQ:EDAPFree Report) in a report released on Thursday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

A number of other equities analysts have also commented on the company. Jefferies Financial Group reaffirmed a “hold” rating and issued a $2.00 price target (down from $8.00) on shares of Edap Tms in a report on Friday, April 4th. HC Wainwright reissued a “buy” rating and set a $19.00 price objective on shares of Edap Tms in a report on Friday, March 28th. Finally, Piper Sandler reduced their target price on Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a report on Friday, March 28th.

Check Out Our Latest Stock Analysis on Edap Tms

Edap Tms Price Performance

EDAP opened at $1.76 on Thursday. The firm has a 50-day moving average price of $1.93 and a 200-day moving average price of $2.26. Edap Tms has a twelve month low of $1.26 and a twelve month high of $7.00. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $65.30 million, a price-to-earnings ratio of -2.71 and a beta of 0.13.

Edap Tms (NASDAQ:EDAPGet Free Report) last released its quarterly earnings data on Thursday, May 15th. The medical equipment provider reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.04). Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. Equities analysts expect that Edap Tms will post -0.6 EPS for the current year.

Institutional Trading of Edap Tms

A number of hedge funds and other institutional investors have recently bought and sold shares of EDAP. Banque Transatlantique SA boosted its holdings in Edap Tms by 7,063.7% in the 1st quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider’s stock valued at $1,324,000 after purchasing an additional 720,499 shares during the period. Scoggin Management LP purchased a new stake in shares of Edap Tms in the first quarter worth $686,000. Jane Street Group LLC boosted its stake in Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after buying an additional 73,361 shares during the period. Schonfeld Strategic Advisors LLC boosted its stake in Edap Tms by 48.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after buying an additional 52,500 shares during the period. Finally, Millennium Management LLC grew its position in Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after buying an additional 33,558 shares in the last quarter. Institutional investors own 62.74% of the company’s stock.

About Edap Tms

(Get Free Report)

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.

Featured Articles

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.